DOI: https://doi.org/10.22141/2224-0551.13.0.2018.131187

Correction of gut microbiota in the treatment of irritable bowel syndrome in children

V.I. Berezutsky

Abstract


The purpose of the work was to determine the possibilities of gut microbiota correction in the treatment of children with irritable bowel syndrome according to the analysis of scientific publications 2016–2018 in journals indexed by Scopus, WоS, MedLine and PubMed. The analysis showed that disturbances of gut microbiota play a major role in the pathogenesis of irritable bowel syndrome in children. The most effective method for the correction of intestinal dysbiosis is the combined use of probiotics and diet with fermentable carbohydrate restriction. The most effective schemes for the use of probiotics have not yet been determined, this question is the subject of further research. The positive effect of dietary fiber (including Psyllium) at this time has not been proven. The popularization of the accumula­ted experience of intestinal microbiota correction in children with irritable bowel syndrome is a necessary condition to increase the effectiveness of treatment for this disease in public health-care.

Keywords


irritable bowel syndrome; microbiota; diet; probiotics; review

References


Rukunuzzaman M, Karim AB, Nurullah M, et al. Irritable Bowel Syndrome: Is it Rare in Children? Mymensingh Med J. 2018 Jan;27(1):216-221.

Mujagic Z, Jonkers D, Hungin AP, et al. Use of Rome criteria for the diagnosis of irritable bowel syndrome in primary care: a survey among European countries. Eur J Gastroenterol Hepatol. 2017 Jun;29(6):651-656. doi: 10.1097/MEG.0000000000000848.

Robin SG, Keller C, Zwiener R, et al. Prevalence of Pediatric Functional Gastrointestinal Disorders Utilizing the Rome IV Criteria. J Pediatr. 2018 Apr;195:134-139. doi: 10.1016/j.jpeds.2017.12.012.

Ringel Y. The gut microbiome in irritable bowel syndrome and other functional bowel disorders. Gastroenterol Clin North Am. 2017 Mar;46(1):91-101. doi: 10.1016/j.gtc.2016.09.014.

Allen AP, Dinan TG, Clarke G, Cryan JF. A psychology of the human brain–gut–microbiome axis. Soc Personal Psychol Compass. 2017 Apr;11(4):e12309. doi: 10.1111/spc3.12309.

de Weerth C. Do bacteria shape our development? Crosstalk between intestinal microbiota and HPA axis. Neurosci Biobehav Rev. 2017 Dec;83:458-471. doi: 10.1016/j.neubiorev.2017.09.016.

Pusceddu MM, Murray K, Gareau MG. Targeting the Microbiota, From Irritable Bowel Syndrome to Mood Disorders: Focus on Probiotics and Prebiotics. Curr Pathobiol Rep. 2018:6(1):1-13. doi: 10.1007/s40139-018-0160-3.

O'Mahony SM, Dinan TG, Cryan JF. The gut microbiota as a key regulator of visceral pain. Pain. 2017 Apr;158 Suppl 1:S19-S28. doi: 10.1097/j.pain.0000000000000779.

Oświęcimska J, Szymlak A, Roczniak W, Girczys-Połedniok K, Kwiecień J. New insights into the pathogenesis and treatment of irritable bowel syndrome. Adv Med Sci. 2017 Mar;62(1):17-30. doi: 10.1016/j.advms.2016.11.001.

Bhesania N, Cresci GA. A nutritional approach for managing irritable bowel syndrome. Curr Opin Pediatr. 2017 Oct;29(5):584-591. doi: 10.1097/MOP.0000000000000536.

Kridler J, Kamat D. Irritable bowel syndrome: A review for general pediatricians. Pediatr Ann. 2016 Jan;45(1):e30-3. doi: 10.3928/00904481-20151208-01.

Rukunuzzaman M, Karim B, Mazumder W, Nurullah M, Hussain F, Sultana K. Approach to a Child with Irritable Bowel Syndrome: A Review. Journal of National Institute of Neurosciences Bangladesh. 2017;2(1):34-39. doi: 10.3329/jninb.v2i1.32969.

Giannetti E, Maglione M, Sciorio E, Coppola V, Miele E, Staiano A. Children are likely to grow out of irritable bowel syndrome. Digestive and Liver Disease. 2016;48(Suppl 4):e252-e253. doi: 10.1016/j.dld.2016.08.032.

Giannetti E,  Maglione M,  Sciorio E,  Coppola V,  Miele E,  Staiano A. Do Children Just Grow Out of Irritable Bowel Syndrome? J Pediatr. 2017 Apr;183:122-126.e1. doi: 10.1016/j.jpeds.2016.12.036.

Distrutti E, Monaldi L, Ricci P, Fiorucci S. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol. 2016 Feb 21;22(7):2219-41. doi: 10.3748/wjg.v22.i7.2219.

Chataway E, Koloski NA, Jones MP, Pachana N, Talley NJ, Holtmann GJ. Is the Association Between Psychological Distress and Irritable Bowel Syndrome Acting Indirectly via Early Childhood Microbial Exposure Factors? Gastroenterology. 2017;152(5; Suppl 1):S725. doi: 10.1016/S0016-5085(17)32520-9.

Koppen IJN, Nurko S, Saps M, Di Lorenzo C, Benninga MA. The pediatric Rome IV criteria: what’s new? Expert Rev Gastroenterol Hepatol. 2017 Mar;11(3):193-201. doi: 10.1080/17474124.2017.1282820.

Benninga MA, Vink M, Akkermans LMA. Intestinal microbiota and its role in the development of paediatric gastrointestinal disorders. In: Browne PD, Claassen E, Cabana MD, editors. Microbiota in health and disease: from pregnancy to childhood. Netherlands: Wageningen Academic Publishers; 2017. 197-216 pp. doi: 10.3920/978-90-8686-839-1_11.

Principi N, Cozzali R, Farinelli E, Brusaferro A, Esposito S. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics. J Infect. 2018 Feb;76(2):111-120. doi: 10.1016/j.jinf.2017.12.013.

Allen AP, Clarke G, Cryan JF, Quigley EMM, Dinan TG. Bifidobacterium infantis 35624 and other probiotics in the management of irritable bowel syndrome. Strain specificity, symptoms, and mechanisms. Curr Med Res Opin. 2017 Jul;33(7):1349-1351. doi: 10.1080/03007995.2017.1322571.

Abrahamsson TR, Wu RY, Sherman PM. Microbiota in Functional Gastrointestinal Disorders in Infancy: Implications for Management. Nestle Nutr Inst Workshop Ser. 2017;88:107-115. doi: 10.1159/000455219.

Artan R, Basturk A, Yilmaz A. Are Synbiotics (bifidobacterium Lactis B94, Inulin) Better Than Probiotics (bifidobacterium Lactis B94) And Prebiotics (inulin) For Irritable Bowel Syndrome In Children? Journal of Pediatric Gastroenterology and Nutrition. 2016;63(1S):S55-S56. doi: 10.1097/01.mpg.0000489633.55998.fa.

Weizman Z, Abu-Abed J, Binsztok M. Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double-blind, placebo-controlled trial. J Pediatr. 2016 Jul;174:160-164.e1. doi: 10.1016/j.jpeds.2016.04.003.

Ahyani T, Supriatmo S, Deliana M, Yudiyanto AR, Sinuhaji AB. Lactobacillus probiotics for treating functional dyspepsia in children. Paediatrica Indonesiana. 2016;56(1):37-42. doi: 10.14238/pi56.1.2016.37-42.

Jadrešin O, Hojsak I, Mišak Z, et al. Lactobacillus reuteri dsm 17938 in the treatment of functional abdominal pain in children: RCT study. J Pediatr Gastroenterol Nutr. 2017 Jun;64(6):925-929. doi: 10.1097/MPG.0000000000001478.

Maragkoudaki M, Chouliaras G, Orel R, Horvath A, Szajewska H, Papadopoulou A. Lactobacillus reuteri DSM 17938 and a placebo both significantly reduced symptoms in children with functional abdominal pain. Acta Paediatr. 2017 Nov;106(11):1857-1862. doi: 10.1111/apa.13992.

Giannetti E, Staiano A. Probiotics for irritable bowel syndrome: clinical data in children. J Pediatr Gastroenterol Nutr. 2016 Jul;63 Suppl 1:S25-6. doi: 10.1097/MPG.0000000000001220.

Giannetti E, Maglione M, Alessandrella A, et al. A mixture of 3 bifidobacteria decreases abdominal pain and improves the quality of life in children with irritable bowel syndrome: a multicenter, randomized, double-blind, placebo-controlled, crossover trial. J Clin Gastroenterol. 2017 Jan;51(1):e5-e10. doi: 10.1097/MCG.0000000000000528.

Staiano A. Microbiotica and probiotics in pediatric irritable bowel syndrome. Journal of Pediatric Gastroenterology and Nutrition. 2016;63(1S):S48-S49. doi: 10.1097/01.mpg.0000489619.74817.34.

Pinto-Sanchez MI, Hall GB, Ghajar K, et al. Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome. Gastroenterology. 2017 Aug;153(2):448-459.e8. doi: 10.1053/j.gastro.2017.05.003.

Tuck CJ, Vanner SJ. Dietary therapies for functional bowel symptoms: Recent advances, challenges, and future directions. Neurogastroenterol Motil. 2018 Jan;30(1):1-20. doi: 10.1111/nmo.13238.

Staudacher HM, Whelan K. The low Fodmap diet: recent advances in understanding its mechanisms and efficacy in IBS. Gut. 2017 Aug;66(8):1517-1527. doi: 10.1136/gutjnl-2017-313750.

Gibson PR. History of the low FODMAP diet. J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:5-7. doi: 10.1111/jgh.13685.

Nanayakkara WS, Skidmore P, O’Brien L, Wilkinson TJ, Gearry RB. Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. Clin Exp Gastroenterol. 2016 Jun 17;9:131-42. doi: 10.2147/CEG.S86798.

Gibson PR. The evidence base for efficacy of the low FODMAP diet in irritable bowel syndrome: is it ready for prime time as a first‐line therapy? J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:32-35. doi: 10.1111/jgh.13693.

O'keeffe M, Lomer MC. Who should deliver the low FODMAP diet and what educational methods are optimal: a review. J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:23-26. doi: 10.1111/jgh.13690.

Whelan K, Martin LD, Staudacher HM, Lomer MCE. The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice. J Hum Nutr Diet. 2018 Apr;31(2):239-255. doi: 10.1111/jhn.12530.

Hill P, Muir JG, Gibson PR. Controversies and recent developments of the low-FODMAP diet. Gastroenterol Hepatol (N Y). 2017 Jan;13(1):36-45.

Iacovou M. Adapting the low FODMAP diet to special populations: infants and children. J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:43-45. doi: 10.1111/jgh.13696.

Boradyn KM, Przybylowicz KE. Low FODMAP diet: a potential treatment of functional abdominal pain in children. Perspect Public Health. 2017 Nov;137(6):314-315. doi: 10.1177/1757913917730253.

Altobelli E, Del Negro V, Angeletti PM, Latella G. Low-FODMAP diet improves irritable bowel syndrome symptoms: a meta-analysis. Nutrients. 2017 Aug 26;9(9). pii: E940. doi: 10.3390/nu9090940.

O'keeffe M, Jansen C,  Martin L,  et al. Long‐term impact of the low‐FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability, and healthcare utilization in irritable bowel syndrome. Neurogastroenterol Motil. 2018 Jan;30(1). doi: 10.1111/nmo.13154.

Dimidi E, Rossi M, Whelan K. Irritable bowel syndrome and diet: where are we in 2018? Curr Opin Clin Nutr Metab Care. 2017 Nov;20(6):456-463. doi: 10.1097/MCO.0000000000000416.

Staudacher HM, Whelan K. Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet. Proc Nutr Soc. 2016 Aug;75(3):306-18. doi: 10.1017/S0029665116000021.

Wegh CAM, Schoterman MHC, Vaughan EE, Belzer C, Benninga MA. The effect of fiber and prebiotics on children’s gastrointestinal disorders and microbiome. Expert Rev Gastroenterol Hepatol. 2017 Nov;11(11):1031-1045. doi: 10.1080/17474124.2017.1359539.

Staudacher HM, Lomer MC, Farquharson FM, et al. A diet low in FODMAPs reduces symptoms in patients with irritable bowel syndrome and a probiotic restores Bifidobacterium species: a randomized controlled trial. Gastroenterology. 2017 Oct;153(4):936-947. doi: 10.1053/j.gastro.2017.06.010.

Harper A, Naghibi MM, Garcha D. The Role of Bacteria, Probiotics and Diet in Irritable Bowel Syndrome. Foods. 2018 Jan 26;7(2). pii: E13. doi: 10.3390/foods7020013.

El-Salhy M, Ystad SO, Mazzawi T, Gundersen D. Dietary fiber in irritable bowel syndrome (Review). Int J Mol Med. 2017 Sep;40(3):607-613. doi: 10.3892/ijmm.2017.3072.

Shulman RJ, Hollister EB, Cain K, et al. Psyllium fiber reduces abdominal pain in children with irritable bowel syndrome in a randomized, double-blind trial. Clin Gastroenterol Hepatol. 2017 May;15(5):712-719.e4. doi: 10.1016/j.cgh.2016.03.045.

Hoekman DR, Zeevenhooven J, Benninga MA. Should We Treat Our Pediatric Irritable Bowel Syndrome Patients With Psyllium? Clin Gastroenterol Hepatol. 2016 Nov;14(11):1667. doi: 10.1016/j.cgh.2016.06.001.

Gupta S, Schaffer G, Saps M. Pediatric Irritable Bowel Syndrome and Other Functional Abdominal Pain Disorders: An Update of Non-Pharmacological Treatments. Expert Rev Gastroenterol Hepatol. 2018 May;12(5):447-456. doi: 10.1080/17474124.2018.1462699.




Copyright (c) 2018 CHILD`S HEALTH

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2018

 

   Seo анализ сайта